<DOC>
	<DOCNO>NCT01095094</DOCNO>
	<brief_summary>RATIONALE : Ritonavir lopinavir may stop growth glioma block enzyme need cell growth block blood flow tumor . PURPOSE : This phase II trial study well give ritonavir together lopinavir work treat patient progressive recurrent high-grade glioma .</brief_summary>
	<brief_title>Ritonavir Lopinavir Treating Patients With Progressive Recurrent High-Grade Glioma</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate 6-month progression-free survival patient recurrent progressive high grade glioma treat ritonavir lopinavir . SECONDARY OBJECTIVES : I . To evaluate toxicity ritonavir lopinavir patient population . OUTLINE : Patients receive oral ritonavir lopinavir twice daily absence disease progression unacceptable toxicity . After completion study therapy , patient follow periodically .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Gliosarcoma</mesh_term>
	<mesh_term>Ependymoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>Histologically proven high grade glioma ( WHO grade 34 ) progressive recurrent follow radiation therapy without chemotherapy Patients previous low grade glioma progress radiotherapy chemotherapy biopsied find high grade glioma eligible Patients must recover toxicity prior therapy An interval &gt; = 3 month must elapse since completion recent course radiation therapy Minimum interval since last drug therapy : 2 week since last noncytotoxic therapy ; 3 week must elapse since completion nonnitrosourea contain chemotherapy regimen ; 6 week since completion nitrosourea contain chemotherapy regimen Patients must Karnofsky performance status &gt; = 60 % ( i.e. , must able care himself/herself occasional help others ) Patients must normal hematologic , renal , liver function ( i.e. , absolute neutrophil count &gt; = 1500/mm^3 , platelet &gt; = 100,000/mm^3 , HgB &gt; 9 d/dl , creatinine = &lt; 1.5mg/dl , total bilirubin = &lt; 1.5mg/dl , transaminase = &lt; 2.5 time upper limit institutional norm ) Patients must able provide write informed consent Patients potential pregnancy impregnate partner must agree follow acceptable birth control method avoid contraception Female patient childbearing potential must negative pregnancy test Patients must concurrent malignancy except curatively treat basal squamous cell carcinoma skin carcinoma situ cervix breast , adequately treated stage I II cancer patient complete remission Patients prior malignancy must diseasefree &gt; = 3 year Patients must maintain stable corticosteroid regimen time baseline scan start treatment Patients must Mini mental state exam score &gt; = 15 Patients serious concurrent infection medical illness , would jeopardize ability patient receive treatment outline protocol reasonable safety Patients pregnant breastfeeding Patients receive concurrent therapy tumor ( exception steroid ) HIV positive Prior therapy HIV protease inhibitor Concurrent therapy hepatic enzyme induce anticonvulsant Inability follow closely Cleveland Clinic Patients require use medication wellknown contraindicate concomitant use lopinavir/ritonavir : amiodarone , astemizole , bepridil , bupropione , cisapride , clorazepate , clozapim , diazepam , encainide , flecainide , flurazepam , meperidine , midazolam , primozide , piroxicam , propafenone , propoxifeno , quinidine , rifabutin , terfenadine , triazolam , zolpidem , dihydroergotamine , ergotamine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>adult brain tumor</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
</DOC>